187 related articles for article (PubMed ID: 19199896)
1. Pegaptanib sodium for the treatment of proliferative diabetic retinopathy and diabetic macular edema.
Giuliari GP; Guel DA; Gonzalez VH
Curr Diabetes Rev; 2009 Feb; 5(1):33-8. PubMed ID: 19199896
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
Morjaria R; Chong NV
Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1185-92. PubMed ID: 24856361
[TBL] [Abstract][Full Text] [Related]
3. Pegaptanib octasodium for the treatment of diabetic macular edema.
Schartman JP; Coney JM; Hornik JH; Miller DG
Expert Opin Pharmacother; 2011 Jun; 12(8):1317-1323. PubMed ID: 21548719
[No Abstract] [Full Text] [Related]
4. Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.
Giuliari GP; Guel DA; Cortez MA; Cortez RT
Can J Ophthalmol; 2010 Oct; 45(5):501-8. PubMed ID: 20648074
[TBL] [Abstract][Full Text] [Related]
5. Diabetic retinopathy: current and new treatment options.
Giuliari GP
Curr Diabetes Rev; 2012 Jan; 8(1):32-41. PubMed ID: 22352446
[TBL] [Abstract][Full Text] [Related]
6. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.
Sultan MB; Zhou D; Loftus J; Dombi T; Ice KS;
Ophthalmology; 2011 Jun; 118(6):1107-18. PubMed ID: 21529957
[TBL] [Abstract][Full Text] [Related]
7. Antivascular endothelial growth factor in diabetic retinopathy.
Iacono P; Battaglia Parodi M; Bandello F
Dev Ophthalmol; 2010; 46():39-53. PubMed ID: 20703031
[TBL] [Abstract][Full Text] [Related]
8. Diabetic macular edema.
Lang GE
Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
[TBL] [Abstract][Full Text] [Related]
9. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenesis drugs in diabetic retinopathy.
Jeganathan VS
Curr Pharm Biotechnol; 2011 Mar; 12(3):369-72. PubMed ID: 20939797
[TBL] [Abstract][Full Text] [Related]
11. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF Molecules for the Management of Diabetic Macular Edema.
Bandello F; Cicinelli MV; Parodi MB
Curr Pharm Des; 2015; 21(32):4731-7. PubMed ID: 26350530
[TBL] [Abstract][Full Text] [Related]
13. Current and investigational drugs for the treatment of diabetic retinopathy.
Tolentino MS; Tolentino AJ; Tolentino MJ
Expert Opin Investig Drugs; 2016 Sep; 25(9):1011-22. PubMed ID: 27367620
[TBL] [Abstract][Full Text] [Related]
14. Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.
Loftus JV; Sultan MB; Pleil AM;
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7498-505. PubMed ID: 21896838
[TBL] [Abstract][Full Text] [Related]
15. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
[TBL] [Abstract][Full Text] [Related]
16. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
Cunningham ET; Adamis AP; Altaweel M; Aiello LP; Bressler NM; D'Amico DJ; Goldbaum M; Guyer DR; Katz B; Patel M; Schwartz SD;
Ophthalmology; 2005 Oct; 112(10):1747-57. PubMed ID: 16154196
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for diabetic retinopathy.
Arevalo JF; Garcia-Amaris RA
Curr Diabetes Rev; 2009 Feb; 5(1):39-46. PubMed ID: 19199897
[TBL] [Abstract][Full Text] [Related]
18. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.
Berrocal MH; Acaba LA; Chenworth ML
Curr Diab Rep; 2019 Sep; 19(10):106. PubMed ID: 31529405
[TBL] [Abstract][Full Text] [Related]
19. Anti-VEGF therapeutic approaches for diabetic macular edema.
Khurana RN; Do DV; Nguyen QD
Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
[No Abstract] [Full Text] [Related]
20. Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.
Chong V
Ophthalmologica; 2012; 227 Suppl 1():2-10. PubMed ID: 22517120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
